Related Experiment Video
Updated: Aug 17, 2026

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
[Mechanism and treatment of cancer metastasis to bone]
1Department of Biochemistry, Osaka University Graduate School of Dentistry.
Abstract:
Bone is one of the most preferential metastatic target sites for cancers such as breast, prostate and lung cancers. Although the precise molecular mechanisms underlying this predilection are still unclear, it appears that these cancer cells possess the capacity to modulate bone microenvironments for them to arrest, survive and proliferate. In particular, the production of bone-resorbing cytokines by these cancer cells increases osteoclastic bone resorption, which in turn facilitates the colonization of these cancer cells in bone through abundant supplies of bone-stored growth factors. This crosstalk between metastatic cancer cells and bone promotes the development and progression of bone metastases. Disruption of this vicious cycle using bisphosphonates will allow us to effectively and specifically inhibit bone metastases.
Insights
Cancer cells preferentially metastasize to bone by altering the bone microenvironment. Targeting this process with bisphosphonates can inhibit bone metastases development and progression.
Area of Science:
- Oncology
- Bone Biology
- Cancer Metastasis
Context:
- Bone is a common site for metastasis from breast, prostate, and lung cancers.
- Cancer cells interact with the bone microenvironment to facilitate their colonization and growth.
- The precise molecular mechanisms driving bone tropism are not fully understood.
Purpose:
- To elucidate the mechanisms by which cancer cells establish bone metastases.
- To highlight the role of cancer cell-induced bone resorption in metastasis.
- To propose bisphosphonates as a therapeutic strategy to disrupt this process.
Summary:
- Cancer cells modulate the bone microenvironment, promoting their survival and proliferation.
- Cancer cells produce cytokines that increase osteoclastic bone resorption.
- This resorption releases growth factors, further supporting cancer cell colonization and promoting bone metastasis development.
Impact:
- Understanding the cancer cell-bone crosstalk is crucial for developing effective treatments.
- Bisphosphonates can disrupt the cycle of bone resorption and cancer cell growth.
- Targeting bone metastases can improve patient outcomes for common cancers.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

